{
    "2018-10-26": [
        [
            {
                "time": "2018-10-26",
                "original_text": "Court Issues Ruling in ZYTIGA® Patent Infringement Litigation",
                "features": {
                    "keywords": [
                        "ZYTIGA",
                        "Patent",
                        "Infringement",
                        "Litigation"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-26",
                "original_text": "Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO",
                "features": {
                    "keywords": [
                        "MRK",
                        "BMY",
                        "Q3",
                        "Earnings",
                        "Cancer",
                        "Data",
                        "ESMO"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-26",
                "original_text": "The health and wellness industry is making healthy profits",
                "features": {
                    "keywords": [
                        "health",
                        "wellness",
                        "profits"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-26",
                "original_text": "'A New Way To Treat The Brain': Stanford University Scientists Launch Cannabis Pharma Company",
                "features": {
                    "keywords": [
                        "Stanford",
                        "University",
                        "Cannabis",
                        "Pharma",
                        "Company"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-26",
                "original_text": "Celgene’s Revlimid and Pomalyst Saw Solid Q3 Growth",
                "features": {
                    "keywords": [
                        "Celgene",
                        "Revlimid",
                        "Pomalyst",
                        "Q3",
                        "Growth"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-26",
                "original_text": "How Is JNJ’s Cardiovascular & Metabolism Business Positioned?",
                "features": {
                    "keywords": [
                        "JNJ",
                        "Cardiovascular",
                        "Metabolism",
                        "Business"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-26",
                "original_text": "Health Care Sector Update for 10/26/2018: SGYP, RARE, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health",
                        "Care",
                        "Sector",
                        "SGYP",
                        "RARE",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-26",
                "original_text": "A Performance Overview of JNJ’s Imbruvica, Velcade, and Zytiga",
                "features": {
                    "keywords": [
                        "JNJ",
                        "Imbruvica",
                        "Velcade",
                        "Zytiga"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-26",
                "original_text": "Johnson & Johnson’s Oncology Business Saw Solid Growth in Q3",
                "features": {
                    "keywords": [
                        "Johnson",
                        "&",
                        "Johnson",
                        "Oncology",
                        "Business",
                        "Q3",
                        "Growth"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}